These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 12093771)
1. Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period: a population-based study of elderly men. Björklund K; Lind L; Vessby B; Andrén B; Lithell H Circulation; 2002 Jul; 106(1):63-8. PubMed ID: 12093771 [TBL] [Abstract][Full Text] [Related]
2. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Liu JE; Roman MJ; Pini R; Schwartz JE; Pickering TG; Devereux RB Ann Intern Med; 1999 Oct; 131(8):564-72. PubMed ID: 10523216 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Weber MA; Neutel JM; Smith DH; Graettinger WF Circulation; 1994 Nov; 90(5):2291-8. PubMed ID: 7955186 [TBL] [Abstract][Full Text] [Related]
4. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Palatini P; Mormino P; Santonastaso M; Mos L; Dal Follo M; Zanata G; Pessina AC Hypertension; 1998 Jan; 31(1):57-63. PubMed ID: 9449391 [TBL] [Abstract][Full Text] [Related]
5. Masked hypertension and target organ damage in treated hypertensive patients. Tomiyama M; Horio T; Yoshii M; Takiuchi S; Kamide K; Nakamura S; Yoshihara F; Nakahama H; Inenaga T; Kawano Y Am J Hypertens; 2006 Sep; 19(9):880-6. PubMed ID: 16942927 [TBL] [Abstract][Full Text] [Related]
6. Frequency and determinants of white coat hypertension in mild to moderate hypertension: a primary care-based study. Monitorización Ambulatoria de la Presión Arterial (MAPA)-Area 5 Working Group. Martínez MA; García-Puig J; Martín JC; Guallar-Castillón P; Aguirre de Cárcer A; Torre A; Armada E; Nevado A; Madero RS Am J Hypertens; 1999 Mar; 12(3):251-9. PubMed ID: 10192226 [TBL] [Abstract][Full Text] [Related]
7. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"]. Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654 [TBL] [Abstract][Full Text] [Related]
8. White coat hypertension and target organ involvement: the impact of different cut-off levels on albuminuria and left ventricular mass and geometry. Høegholm A; Kristensen KS; Bang LE; Nielsen JW J Hum Hypertens; 1998 Jul; 12(7):433-9. PubMed ID: 9702928 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical significance of a greater ambulatory versus office blood pressure ('reversed white coat' condition) in a general population. Bombelli M; Sega R; Facchetti R; Corrao G; Polo Friz H; Vertemati AM; Sanvito R; Banfi E; Carugo S; Primitz L; Mancia G J Hypertens; 2005 Mar; 23(3):513-20. PubMed ID: 15716691 [TBL] [Abstract][Full Text] [Related]
10. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Cavallini MC; Roman MJ; Pickering TG; Schwartz JE; Pini R; Devereux RB Hypertension; 1995 Sep; 26(3):413-9. PubMed ID: 7649575 [TBL] [Abstract][Full Text] [Related]
11. White-coat hypertension and cardiac organ damage in elderly subjects. Rizzo V; Cicconetti P; Bianchi A; Lorido A; Morelli S; Vetta F; Salza MC; Marigliano V J Hum Hypertens; 1996 May; 10(5):293-8. PubMed ID: 8817402 [TBL] [Abstract][Full Text] [Related]
12. Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. Muscholl MW; Hense HW; Bröckel U; Döring A; Riegger GA; Schunkert H BMJ; 1998 Aug; 317(7158):565-70. PubMed ID: 9721112 [TBL] [Abstract][Full Text] [Related]
13. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index. Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516 [TBL] [Abstract][Full Text] [Related]
14. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients. Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262 [TBL] [Abstract][Full Text] [Related]
15. Circulating homocysteine levels in sustained and white coat hypertension. Pierdomenico SD; Bucci A; Lapenna D; Lattanzio FM; Talone L; Cuccurullo F; Mezzetti A J Hum Hypertens; 2003 Mar; 17(3):165-70. PubMed ID: 12624606 [TBL] [Abstract][Full Text] [Related]
19. Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain. Gorostidi M; Sarafidis PA; de la Sierra A; Segura J; de la Cruz JJ; Banegas JR; Ruilope LM; Am J Kidney Dis; 2013 Aug; 62(2):285-94. PubMed ID: 23689071 [TBL] [Abstract][Full Text] [Related]